Evaluation of a recombinant antigen enzyme-linked immunosorbent assay (ELISA) in the diagnostics of antinuclear antibodies (ANA) in children with rheumatic disorders

Clinical Rheumatology

Volumn 21, Issue 2, 2002, Pages 103-107

  Reiff, A ^a   Haubruck, H ^b   Amos, M D ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DIARECT AG   (Germany)

^c Life Technologies Inc   (United States)

Author keywords

ANA; Children; ELISA; IFA; Rheumatology

Indexed keywords

ANTINUCLEAR ANTIBODY; RECOMBINANT ANTIGEN;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RELIABILITY; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; EPIDEMIOLOGY; EVALUATION; PRESCHOOL CHILD; PROBABILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMPARATIVE STUDY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROBABILITY; RHEUMATIC DISEASES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0035985603     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-8269-4     Document Type: Article

References (24)

1. Antinuclear antibodies using Hep-2 cells in normal children and in children with common infections
2. Antinuclear antibodies in children with chronic nonspecific complains
3. The prevalence of antinuclear, anti-dsDNA, anti-Sm, and anti-RNP antibodies in a group of healthy blood donors
4. Range of antinuclear antibodies in healthy individuals
5. Antinuclear antibodies in healthy aging
6. Demonstration of antibodies against human malignant melanoma by immunofluorescence
7. Antinucleolar antibodies in the sera of patients with malignant melanoma
8. Human leukemia-associated anti-nuclear reactivity
9. Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases
10. Autoantibodies in the sera of patients with nasopharyngeal carcinoma
11. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients
12. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis
13. Diversity of antinuclear antibody responses in hepatocellular carcinoma
14. Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first degree relatives
15. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy
16. Antinuclear autoantibodies in chronic schizophrenia
17. Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine
18. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
19. Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis
20. Evaluation of enzyme immunoassay (EIA) antinuclear antibody (ANA) screening detection systems in the pediatric population
21. ANA ELISA as a screen for ANA associated with connective tissue disease: Comparative analysis of ANA ELISAs on serum samples tested by Hep-2 IFA followed by antigen identity analysis by western blot and ELISA for specificities
22. Screening for antinuclear antibodies by enzyme immunoassays
23. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease
24. Uveitis associated with juvenile rheumatoid arthritis